PAEDIATRICS: Level 3 and Level 4 devices for diagnosis of sleep disordered breathing in children with neurodisability: considerations, challenges and comparisons with PSG
Tracks
Track 2
| Thursday, October 9, 2025 |
| 3:30 PM - 5:00 PM |
Details
This symposium will discuss alternatives to in lab level 1 PSG for children with neurodisability who are one of the largest sub-populations of children who undergo evaluation for SDB in tertiary centres. Comparison data from clinical trials and pilot studies undertaken with level 2 and 3 devices will be presented, focusing on the specific benefits and challenges with these devices in children with neurodisability.
Speaker
Dr Adelaide Withers
Respiratory And Sleep Consultant
Perth Children's Hospital
Comparison with level 1 PSG: Home level 2 PSG for the diagnosis of sleep disordered breathing in children with neurodisability
3:30 PM - 3:47 PMBiography
Anne-Marie Adams
Level 3 and level 4 devices for diagnosis of SDB in children - what's available and what's the evidence in children?
3:47 PM - 4:04 PMBiography
Moya Vandeleur
Royal Children's Hospital Melbourne
Pros and cons of level 3 and 4 devices in children with neurodisability, including consumer perspectives
4:04 PM - 4:21 PMBiography
Andrew Collaro
Comparison with level 1 PSG: (1) Machine-learning pulse oximetry analysis and (2) mandibular movement monitoring for the detection of SDB in children with neurodisability
4:21 PM - 4:38 PMBiography
Assoc Prof Jasneek Chawla
Paediatric Respiratory And Sleep Specialist
Queensland Children’s Hospital
Comparison with level 1 PSG: Results of an Australian multi-centre clinical trial of the Sonomat Sleep Mat System for diagnosis of SDB in children with neurodisability
4:38 PM - 4:55 PMBiography
Karen Waters
Chair
Biography
Dr Ajay Kevat
Senior Medical Officer
Queensland Children's Hospital
Chair
Biography
